中国寄生虫学与寄生虫病杂志

• 综述 • 上一篇    下一篇

恶性疟原虫对青蒿素类药物产生耐药性的全球现状和基础研究

赵绍敏,王满元*   

  1. 首都医科大学中医药学院,北京 100069
  • 出版日期:2014-10-30 发布日期:2015-01-06

Artemisinin Resistance in Plasmodium falciparum:Global Status and Basic Research

ZHAO Shao-min,WANG Man-yuan*   

  1. School of Traditional Chinese Medicine,Capital Medical University,Beijing 100069,China
  • Online:2014-10-30 Published:2015-01-06

摘要:

全球范围内,青蒿素类药物耐药性的产生与蔓延现状严峻。在东南亚大湄公河流域已确定出现对青蒿素类耐药的恶性疟原虫虫株,非洲和南美洲已展开耐药性监控。目前已基本确定与青蒿素类药物耐药性相关的基因片段,并有望应用分子标记对耐药性传播进行大范围监控。本文就近年来对青蒿素类药物产生耐药性的恶性疟原虫的全球现状和基础研究进展作一综述。

关键词: 青蒿素类, 恶性疟原虫, 耐药

Abstract:

Artemisinin-resistant Plasmodium falciparum has been identified by WHO in the Greater Mekong subregion. While there is no report on artemisinin resistance in Africa and South America by now, related surveillance measures have been taken place. The genes related artemisinin-resistance has been identified and the molecular markers will be used for large-scale surveillance efforts to contain artemisinin resistance. The emergence and spread of artemisinin resistance worldwide is a present danger and needs more attention. This article reviews the progress of artemisinin-resistance malaria parasites and artemisinin-based combination therapies.

Key words: Artemisinin;Plasmodium , falciparum;Drug resistance